The clinical research team in the Division of Genetics works on a variety of research studies. These include natural history studies which document the course of disorders before treatment and during treatment. We are also involved in Phase I (first in human) through Phase IV (post-FDA approval) clinical trials. The focus of these trials is to develop new therapies and improve existing therapies. Genetic disorders that are studied include:
Questions or inquiries for any of the clinical research trials can be directed to Rachel Katz, Clinical Research Manager, at 312.227.6764.
